GGrantIndex
Sort

46,585 grants matching heart failure

Short-course Benznidazole Treatment to Reduce Trypanosoma cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiorityRandomized Controlled Trial

$511,095
Pierre Buekens · Tulane University Of Louisiana · R01 · FY2019 · HD

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

$511,028
Michael R Knowles · Univ Of North Carolina Chapel Hill · U54 · FY2022 · HL

STICH Trial-Statistical and Data Coordinatiing Center

$510,961
Duke University · U01 · FY2003 · HL

Mineral Metabolism and Cardiovascular Risk among Older Adults

$510,956
Bryan R Kestenbaum · University Of Washington · R01 · FY2007 · HL

Develop and Validate Tool to Monitor Patient Centered Outcomes Through Caregivers

$510,884
Patrick Oneal Monahan · Indiana University Indianapolis · R01 · FY2014 · AG

Pathophysiology of Heart Failure with a Normal Ejection Fraction in the Elderly

$510,835
Mathew S Maurer · Columbia University Health Sciences · R01 · FY2007 · AG

Cavopulmonary Assist: Circulatory Support for the Univentricular Fontan Circulat

$510,697
Mark D Rodefeld · Indiana University Indianapolis · R01 · FY2010 · HL

Aging, Fitness &Failure: Diastolic Dysfunction

$510,683
University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · AG

Mechanisms Mediating Enhanced Sympatho-Activation During Exercise in Hypertension

$510,676
Donal S. O'Leary · Wayne State University · R01 · FY2017 · HL

Mechanisms underlying atrial fibrillation associated with chronic kidney disease

$510,632
Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2020 · HL

Mechanisms underlying atrial fibrillation associated with chronic kidney disease

$510,632
Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2022 · HL

Mechanisms underlying atrial fibrillation associated with chronic kidney disease

$510,632
Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2021 · HL

Linking cell death and mitochondrial quality control mechanisms in heart disease

$510,624
Richard N Kitsis · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL

Multi-scale systems analysis of blood pressure control and hypertension

$510,610
Daniel A Beard · University Of Michigan At Ann Arbor · R01 · FY2019 · HL

SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)

$510,602
Douglas Lowell Mann · Washington University · U10 · FY2013 · HL

Wnt Signaling in Cardiac Conduction and Arrhythmogenesis

$510,560
Stacey Lynn Rentschler · Washington University · R01 · FY2023 · HL

Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)

$510,532
Ying Xian · Duke University · R01 · FY2019 · AG

Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptides

$510,513
Gee W Lau · University Of Illinois At Urbana-Champaign · R01 · FY2022 · HL

Integrating Volumetric Light-Field with Computational Fluid Dynamics to Study Myocardial Trabeculation and Function

$510,487
Tzung K Hsiai · University Of California Los Angeles · R01 · FY2021 · HL

Development of Serum, Imaging, and Clinical Biomarker Driven Models to Direct Clinical Management after Pediatric Cardiac Arrest

$510,446
Ericka Linn Fink · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · NS

Real-time imaging of skeletal muscle innervating sensory neurons that signal pain and fatigue

$510,410
Charles Jeffery Woodbury · University Of Utah · R01 · FY2018 · NS

Genetics of lipoprotein metabolism and CVD in CKD

$510,376
Daniel James Rader · University Of Pennsylvania · R01 · FY2009 · HL

Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease

$510,309
Kathleen G Morgan · Boston University (Charles River Campus) · R56 · FY2016 · AG

Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy

$510,302
Luisa Mestroni · University Of Colorado Denver · R01 · FY2022 · HL

AKAP-dependent regulation of Cardiac SR Ca handling

$510,252
Donald M Bers · University Of California At Davis · R01 · FY2017 · HL